• / Free eNewsletters & Magazine
  • / My Account
Home>Stocks>Teva Pharmaceutical Industries

Teva Pharmaceutical Industries

  1. All
  2. Morningstar Articles
  3. Videos
  4. 3rd Party
  5. Research
  1. Ambit Biosciences To Announce Second Quarter 2014 Financial Results

    Ambit Biosciences To Announce Second Quarter 2014 Financial Results

  2. Teva Receives CHMP Positive Opinion for Seasonique® Extended-Regimen Contraceptive for Marketing Authorization in Several European Countries

    Teva Receives CHMP Positive Opinion for Seasonique® Extended-Regimen Contraceptive for Marketing Authorization in Several European Countries

  3. Research and Markets: World Market for Biosimilars (EPO, G-CSF, HGH, Insulin, Interferon alpha, mAbs, Others) 2013-2017

    Research and Markets: World Market for Biosimilars (EPO, G-CSF, HGH, Insulin, Interferon alpha, mAbs, Others) 2013-2017

  4. Alexza Pharmaceuticals Announces Participation in Upcoming Investor Conferences

    Alexza Pharmaceuticals Announces Participation in Upcoming Investor Conferences

  5. OncoGenex Announces Cedar™ Clinical Trial Evaluating Apatorsen in Combination with Chemotherapy in Advanced Squamous Cell Lung Cancer is Now Open for Enrollment

    OncoGenex Announces Cedar™ Clinical Trial Evaluating Apatorsen in Combination with Chemotherapy in Advanced Squamous Cell Lung Cancer is Now Open for Enrollment

  6. Research and Markets: PharmaSphere: Regulatory Frameworks and Product Pipelines in the Global Biosimilars Market

    Research and Markets: PharmaSphere: Regulatory Frameworks and Product Pipelines in the Global Biosimilars Market

  7. QRxPharma Announces Board Resignations

    QRxPharma Announces Board Resignations

  8. Our Outlook for the Credit Markets

    Widening investment-grade credit spreads and rising interest rates lead to losses.

12345
Upcoming Events
Conferences
Webinars

©2014 Morningstar Advisor. All right reserved.